Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02662881

Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE — REGP-44-00  

Avascular Necrosis of the Femoral Head Clinical Trial

Official title:
Post-Market Data Collection for Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE

Clinical Trial Summary

This study will evaluate the performance of biologically assisted core decompression with the PerFuse instrument and BioCUE in patients with bone lesions in the femoral head. The study will explore the potential impact of patient demographics and baseline characteristics on post-operative outcomes.

Clinical Trial Description

This study will evaluate the performance of biologically assisted core decompression with the PerFuse instrument and BioCUE in patients with bone lesions in the femoral head. The study will explore the potential impact of patient demographics and baseline characteristics on post-operative outcomes. The study will evaluate change in Harris Hip Score (HHS) at 12 months after treatment. The change in AVN lesion size will also be measured at 12 months after index treatment via MRI. Change in quality of life and pain measures will be measured at each follow-up. Adverse events will also be recorded throughout the study. This study will follow patients for 5 years after initial treatment. Data will be recorded in a online database that will be entered by the site or patient, depending on the report form. This database includes data checks to compare entered data against predefined rules for range. A risk-based monitoring plan will be put in place for source data verification. ;

Study Design

Related Conditions & MeSH terms

  • Avascular Necrosis of the Femoral Head
  • Necrosis
Clinical Trial Details
NCT number NCT02662881
Study type Observational [Patient Registry]
Source Zimmer Biomet
Contact
Status Active, not recruiting
Phase
Start date March 2016
Completion date December 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04731077 - Avenir Complete Post-Market Clinical Follow-Up Study N/A
Recruiting NCT05227924 - Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty
Completed NCT01643655 - Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head N/A
Active, not recruiting NCT05186168 - Corin MiniHip and Trinity Cup Clinical Surveillance Study
Recruiting NCT02552069 - Tritanium® Study in Japan
Recruiting NCT05460715 - The Medacta Quadra-P Anteverted Study
Recruiting NCT02748408 - The Medacta International SMS Post-Marketing Surveillance Study
Not yet recruiting NCT06123481 - Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis N/A
Recruiting NCT02783274 - Actis Total Hip System 2 Year Follow-up N/A
Withdrawn NCT03753282 - Outcome After Avascular Necrosis of the Femoral Head in Young Patients
Completed NCT03639532 - Ceramic-on-Ceramic Versus Ceramic-on-HXLPE THA Phase 4
Completed NCT02065167 - Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip Phase 2
Recruiting NCT05982054 - Bone Marrow Cells With Core Decompression for AVN Treatment N/A
Active, not recruiting NCT04997005 - The Medacta International AMIStem-P Post-Marketing Surveillance Study